Literature DB >> 25951743

Endocrine therapy in breast cancer: the neoadjuvant, adjuvant, and metastatic approach.

Raquel E Reinbolt, Neha Mangini, Jordan L Hill, Lauren B Levine, Jessica L Dempsey, Janani Singaravelu, Kevin A Koehler, Allison Talley, Maryam B Lustberg.   

Abstract

OBJECTIVES: To review the rationale for endocrine therapy in the neoadjuvant, adjuvant, and metastatic breast cancer setting and to highlight clinical considerations unique to this treatment. DATA SOURCES: Contemporary literature, clinical guidelines, and national statistics.
CONCLUSION: Endocrine therapy represents an important strategy in the management of both early and advanced hormone positive breast cancer. Additional research is required to better define the role of neoadjuvant therapy and the optimal duration of treatment. IMPLICATIONS FOR NURSING PRACTICE: Nurses play a pivotal role in the identification and management of endocrine therapy-associated symptoms. Prompt symptom intervention may improve therapy adherence and ultimately, may improve long-term disease outcomes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endocrine therapy; aromatase inhibitors; breast cancer; tamoxifen

Mesh:

Substances:

Year:  2015        PMID: 25951743     DOI: 10.1016/j.soncn.2015.02.002

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  12 in total

1.  Study on the Anticancer Effect of an Astragaloside- and Chlorogenic Acid-Containing Herbal Medicine (RLT-03) in Breast Cancer.

Authors:  Yanchu Li; Xianyong Li; Chen Cuiping; Rong Pu; Yin Weihua
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-10       Impact factor: 2.629

2.  Axillary Response in Patients Undergoing Neoadjuvant Endocrine Treatment for Node-Positive Breast Cancer: Systematic Literature Review and NCDB Analysis.

Authors:  Arielle Stafford; Austin Williams; Kirsten Edmiston; Costanza Cocilovo; Robert Cohen; Sara Bruce; Kahyun Yoon-Flannery; Lucy De La Cruz
Journal:  Ann Surg Oncol       Date:  2020-09-09       Impact factor: 5.344

3.  Effects of Astragaloside IV on treatment of breast cancer cells execute possibly through regulation of Nrf2 via PI3K/AKT/mTOR signaling pathway.

Authors:  Xiao-Qing Zhang; Chang Yao; Wei-He Bian; Xu Chen; Jing-Xian Xue; Zhi-Yuan Zhu; Yu Ying; Yan Lei Xu; Cong Wang
Journal:  Food Sci Nutr       Date:  2019-09-18       Impact factor: 2.863

Review 4.  Estrogen Receptors as Molecular Targets of Endocrine Therapy for Glioblastoma.

Authors:  Andrea Magali González-Mora; Patricia Garcia-Lopez
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

5.  Synergistic Theranostics of Magnetic Resonance Imaging and Photothermal Therapy of Breast Cancer Based on the Janus Nanostructures Fe3O4-Aushell-PEG.

Authors:  Xun Kang; Tao Sun; Liang Zhang; Chunyu Zhou; Zhongsheng Xu; Mengmeng Du; Shilin Xiao; Yun Liu; Mingfu Gong; Dong Zhang
Journal:  Int J Nanomedicine       Date:  2021-09-16

6.  Clinical Features and Serological Markers Risk Model Predicts Overall Survival in Patients Undergoing Breast Cancer and Bone Metastasis Surgeries.

Authors:  Haochen Mou; Zhan Wang; Wenkan Zhang; Guoqi Li; Hao Zhou; Eloy Yinwang; Fangqian Wang; Hangxiang Sun; Yucheng Xue; Zenan Wang; Tao Chen; Xupeng Chai; Hao Qu; Peng Lin; Wangsiyuan Teng; Binghao Li; Zhaoming Ye
Journal:  Front Oncol       Date:  2021-09-17       Impact factor: 6.244

Review 7.  ERα, A Key Target for Cancer Therapy: A Review.

Authors:  Yanfang Liu; Hong Ma; Jing Yao
Journal:  Onco Targets Ther       Date:  2020-03-11       Impact factor: 4.147

8.  Breast Cancer Survivors Undergoing Endocrine Therapy Have a Worrying Risk Factor Profile for Cardiovascular Diseases.

Authors:  Fernanda S Mazzutti; Isis D D Custódio; Mariana T M Lima; Kamila P de Carvalho; Taísa S S Pereira; Maria Del C B Molina; Paula P L Canto; Carlos E Paiva; Yara C de P Maia
Journal:  Nutrients       Date:  2021-03-29       Impact factor: 5.717

9.  The efficacy of gefitinib supplementation for breast cancer: A meta-analysis of randomized controlled studies.

Authors:  Jing Ye; Tian Tian; Xiaopin Chen
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

10.  RAC1 plays an essential role in estrogen receptor alpha function in breast cancer cells.

Authors:  Jun Sun; Gabriel Gaidosh; Ye Xu; Adnan Mookhtiar; Na Man; Pradeep Reddy Cingaram; Ezra Blumenthal; Ramin Shiekhattar; Erik T Goka; Stephen D Nimer; Marc E Lippman
Journal:  Oncogene       Date:  2021-08-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.